Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with high androgen levels may have more severe COVID-19 symptoms.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Scalp hair grows at 0.37 mm/day, forearm hair at 0.18 mm/day, and thigh hair at 0.30 mm/day, with no significant differences found in people with certain hair conditions.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Finasteride may negatively affect male fertility.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Newborn skin is uniquely prepared to adapt to new environments compared to adult skin.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Dermal-epidermal interactions are crucial for hair growth and maintenance.

DA-9401 helps protect rat testis from finasteride damage.

Transferosomes effectively deliver drugs through the skin, improving treatment for skin disorders.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that more research is needed to fully understand the causes of PCOS.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.